Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Tanstrive"

1 News Found

Eli Lilly India launches Tanstrive for RET-altered cancers
Drug Approval | June 25, 2026

Eli Lilly India launches Tanstrive for RET-altered cancers

CDSCO-approved targeted therapy expands precision oncology options for patients with RET-driven lung, thyroid, and other advanced solid tumours